Drupal.behaviors.print = function(context) {window.print();window.close();}>
Finnish Team Takes Metabolomic Approach to Diagnosing, Predicting Progression to Alzheimer’s
December 23, 2011
Finnish Team Takes Metabolomic Approach to Diagnosing, Predicting Progression to Alzheimer’s
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Quanterix and Sony DADC Ink Co-Development Deal for SiMoA Consumables
July 22, 2011 / ProteoMonitor
Gothenburg Scientists ID Tyr10-Glycosylated A-beta as Potential Alzheimer's Biomarker
July 15, 2011 / ProteoMonitor
Quanterix, Gothenberg Researchers Show Potential Link Between Heart Attacks and Alzheimer's Marker
April 15, 2011 / ProteoMonitor
Penn Researchers ID Acetylated Tau as Potential Protein Biomarker for Alzheimer's, Related Disorders
April 8, 2011 / ProteoMonitor
Shifting Focus From Dx Development, Quanterix Aims to Launch Commercial SiMoA Instrument in 2013
February 25, 2011 / ProteoMonitor